Difference between revisions of "Profiles"

From QIBA Wiki
Jump to: navigation, search
(Statements of Endorsement)
(See Also)
Line 49: Line 49:
 
*[[Clinical Sites]]
 
*[[Clinical Sites]]
 
*[[Additional letters of support can be found here]]
 
*[[Additional letters of support can be found here]]
 +
  
 
==See Also==
 
==See Also==

Revision as of 16:05, 10 January 2018

Profiles published here have completed one of the QIBA Profile Stages of development and been approved by their Biomarker Committee.

Stage 3: Technically Confirmed Profiles


Stage 2: Consensus Profiles


Stage 1: Public Comment Profiles

--There are currently no Profiles open for Public Comment--


Please submit all public comments through the following online form: http://tinyurl.com/QIBA-Public-Comment-Form
(Note: each form accommodates 10 comments; you may submit additional forms as necessary)


Public Comment closed for the following Profiles (comment resolution is currently underway):


Format for Citing Profiles


Note to users: When referencing QIBA Profile documents, please use the following format:

Specific QIBA Biomarker Committee. * Specific Profile Title, * Quantitative Imaging Biomarkers Alliance. * Version. * Profile Stage. * QIBA, * Date. * Available from: URL

Format example:

QIBA SPECT Biomarker Committee. Quantifying Dopamine Transporters with 123Iodine Labeled Ioflupane in Neurodegenerative Diseases, Quantitative Imaging Biomarkers Alliance. Version 1.1. Profile Stage: Consensus. QIBA, June 30, 2017. Available from: http://qibawiki.rsna.org/index.php/Profiles


Statements of Endorsement


See Also